Multiple epiphyseal dysplasia (MED) is an autosomal dominant skeletal disorder characterized by early onset osteoarthritis with short stature and stubby fingers. Linkage analyses have identified at least three genetic loci for MED: EDM1 on chro mosome 19,1 EDM2 on chromosome l ,2 and an additional locus.3 EDM1 is caused by mutations in the cartilage oligomeric matrix protein gene (COMP);4 mutations in COMP have also been demonstrated in pseudoachondroplasia (PSACH). 5 We exam ined a large Dutch family with MED and found that the disorders in this family is caused by a mutation in the a2(IX) collagen gene,6 The characteristic clinical fea tures of affected individuals include pain in the knee joints and waddling gait be tween 3 and 6 years of age. X rays of knee joints showed the typical changes of mul tiple epiphyseal dysplasia: flattened, irregular epiphyses, varus/valgus deformity of the knees, and gradually appearing osteoarthritis with or without loose bodies. Link age analysis with microsatellite markers from the EDM1 (D19S199, D19S212, D19S215, D19S222) and EDM2 (D1S186 and MYCL) regions showed significant linkage between the disease and EDM2. 304 ANNALS NEW YORK ACADEMY OF SCIENCES 5 ' . .AAA GCT GGC CCT CCG g t g a g t g c t . . 3 To find the causative mutation we performed RT-PCR with total RNA from short term cultured chondrocytes, obtained during arthroscopic surgery, and from EBV transformed lymphoblasts from an affected patient. First-strand cDNAs were synthe sized with oligo(dT) primers using the Superscript Preamplification System (GIBCO BRL). Since the EDM2 locus includes COL9A2, PCR primers were designed to am plify the approximately 2-kb cDNA coding for a2(IX) collagen in four overlapping fragments. Second-round PCR had to be used to amplify overlapping cDNA frag ments encoding the NC2, COL2, NC3, and COL3 domains and the carboxyl half of the signal peptide of the ot2(IX) collagen chain with nested primers. When the PCR products were analyzed on 2% agarose gels all products were the same size from af fected and unaffected individuals except one containing coding sequences for the COL3 domain, This product migrated as a single band from unaffected individuals and as a double band from affected individuals. Dideoxy-nucleotide cycle sequenc-
• . 7^-.» » . ing (ampliCycle™, Perkin Elmer) showed a 36-nt deletion in the lower band. To bet ter analyze this deletion, second-round PCR was performed with more closely spaced primers; 0.5 |xL of [a-33P] dCTP (10 mM} 2000 Ci/m mol) were added to the reac tion ( Fig. 1 ). Since the 36 nucleotide deletion corresponded to a single exon encod ing part of the amino terminal COL3 domain of the a2(IX) collagen polypeptide (Fig, 1 ), genomic DNA was PCR amplified for further analysis. Cycle sequencing of the genomic PCR products revealed that the sequence of the splice donor site of intron 3, GTGAG, was converted to GCGAG in one allele of the affected patient (F ig . 1). This nucleotide change, A T-to-C transition, resulted in loss of an Hphl site in the genomic sequence of the affected allele. To test for cosegregation of this change with the disorder, we examined the loss of this restriction site in all family members by di gesting genomic PCR products with Hphl. All affected individuals were heterozy gous for this change, while all unaffected individuals were homozygous for the pres-306 ANNALS NEW YORK ACADEMY OF SCIENCES ence of the HphI site (data not shown). We conclude, therefore, that the MED in this family is caused by a splice donor site mutation in intron 3 of the a2(IX) collagen gene, leading to exon skipping during RNA splicing and an in-frame loss of 12 amino acid residues within a triple-helical domain of the polypeptide. The deletion may not have an effect on polypeptide synthesis or formation of collagen IX trimers; however, the mutation may have a dominant negative effect either at the level of pro tein secretion or supramolecular assembly (F ig. 2).
